Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

Español • Italiano • Sardu • English | PDF+


  Ovarian Neoplasms

  Free Subscription


11.11.2019

1 BMC Cancer
1 Clin Cancer Res
2 Gynecol Oncol
2 Int J Cancer
2 J Clin Oncol
1 J Natl Cancer Inst


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMC Cancer

  1. FUNSTON G, Van Melle M, Baun ML, Jensen H, et al
    Variation in the initial assessment and investigation for ovarian cancer in symptomatic women: a systematic review of international guidelines.
    BMC Cancer. 2019;19:1028.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  2. CAUMANNS JJ, Berns K, Wisman GBA, Fehrmann RSN, et al
    Integrative kinome profiling identifies mTORC1/2 inhibition as treatment strategy in ovarian clear cell carcinoma.
    Clin Cancer Res. 2018 Apr 23. pii: 1078-0432.CCR-17-3060.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  3. MATSUO K, Cripe JC, Kurnit KC, Kaneda M, et al
    Recurrence, death, and secondary malignancy after ovarian conservation for young women with early-stage low-grade endometrial cancer.
    Gynecol Oncol. 2019 Aug 16. pii: S0090-8258(19)31458.
    PubMed     Text format     Abstract available

  4. KILTS TP, Glaser GE, Langstraat CL, Kumar A, et al
    Comparing risk stratification criteria for predicting lymphatic dissemination in endometrial cancer.
    Gynecol Oncol. 2019 Aug 10. pii: S0090-8258(19)31456.
    PubMed     Text format     Abstract available


    Int J Cancer

  5. WANG T, Townsend MK, Simmons V, Terry KL, et al
    Pre- and Post- Diagnosis Smoking and Survival Following Diagnosis with Ovarian Cancer.
    Int J Cancer. 2019 Nov 6. doi: 10.1002/ijc.32773.
    PubMed     Text format     Abstract available

  6. SOKOLENKO AP, Bizin IV, Preobrazhenskaya EV, Gorodnova TV, et al
    Molecular Profiles of BRCA1-Associated Ovarian Cancer Treated by Platinum-Based Therapy: Analysis of Primary, Residual and Relapsed Tumours.
    Int J Cancer. 2019 Nov 6. doi: 10.1002/ijc.32776.
    PubMed     Text format     Abstract available


    J Clin Oncol

  7. HAINES IE, Gabor Miklos GL
    Bevacizumab Moonshots: An Important Outcome From the Latest Ovarian Cancer Mission.
    J Clin Oncol. 2019 Nov 7:JCO1901912. doi: 10.1200/JCO.19.01912.
    PubMed     Text format    

  8. FAROLFI A, Lorusso D, Pignata S, De Giorgi U, et al
    Bevacizumab As Maintenance Treatment in Patients With Ovarian Cancer: Wait for BRCA Testing.
    J Clin Oncol. 2019 Nov 7:JCO1902055. doi: 10.1200/JCO.19.02055.
    PubMed     Text format    


    J Natl Cancer Inst

  9. VERDOODT F, Dehlendorff C, Jaattela M, Strauss R, et al
    Antihistamines and ovarian cancer survival: nationwide cohort study and in vitro cell viability assay.
    J Natl Cancer Inst. 2019 Nov 5. pii: 5613208. doi: 10.1093.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: